Published in Eur Surg on October 14, 2015
ROS homeostasis, a key determinant in liver ischemic-preconditioning. Redox Biol (2017) 0.75
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem (2000) 9.07
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med (1993) 5.97
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44
Hepatic ischemia-reperfusion injury. Am J Surg (2001) 3.00
Capillarization of hepatic sinusoids in man. Gastroenterology (1963) 2.60
Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab (2011) 2.42
Protective strategies against ischemic injury of the liver. Gastroenterology (2003) 2.37
Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest (1987) 2.28
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol (1993) 2.14
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer (2007) 2.12
An ultrastructural characterization of the endothelial cell in the rat liver sinusoid under normal and various experimental conditions, as a contribution to the distinction between endothelial and Kupffer cells. J Ultrastruct Res (1972) 1.80
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood (2008) 1.79
The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis. Lab Invest (1985) 1.72
Disordered cellular migration and angiogenesis in cd39-null mice. Circulation (2001) 1.70
Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood (1998) 1.65
Novel insights of dietary polyphenols and obesity. J Nutr Biochem (2014) 1.58
A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction. Ann Surg (2009) 1.44
Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol (2013) 1.29
Metabolism of alcohol. Clin Liver Dis (2005) 1.26
Hepatic microvasculature in liver injury. Semin Liver Dis (2007) 1.24
Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes. Thromb Haemost (1999) 1.20
Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology (2000) 1.18
CXC chemokines play a critical role in liver injury, recovery, and regeneration. Am J Surg (2009) 1.16
Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state. Thromb Res (2012) 1.05
Ischemic preconditioning protects hepatocytes via reactive oxygen species derived from Kupffer cells in rats. Gastroenterology (2004) 1.03
Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1. Cardiovasc Res (2002) 0.96
Leukocyte adhesion and cell death following orthotopic liver transplantation in the rat. Transplantation (1991) 0.95
Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology (1994) 0.95
Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemia-reperfusion in rats. Transplant Proc (2008) 0.94
Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Lab Invest (2003) 0.93
How I treat sinusoidal obstruction syndrome. Blood (2014) 0.93
Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. Gastroenterology (2014) 0.93
Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol (1992) 0.93
Role of platelets in hepatic allograft preservation injury in the rat. Hepatology (1993) 0.92
Global consequences of liver ischemia/reperfusion injury. Oxid Med Cell Longev (2014) 0.90
Veno-occlusive disease/sinusoidal obstruction syndrome associated with potential antibody-mediated rejection after pediatric living donor liver transplantation: a case report. Transplant Proc (2012) 0.90
Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury. Transplant Proc (2008) 0.90
Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance. Vasc Health Risk Manag (2012) 0.88
Mesenchymal stromal cells in renal ischemia/reperfusion injury. Front Immunol (2012) 0.87
Leukocyte stasis in hepatic sinusoids. Am J Physiol (1996) 0.87
Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia. Am J Surg (2014) 0.85
Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J Hepatol (2002) 0.84
Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats. J Pharmacol Exp Ther (1994) 0.84
Suppression of encephalitogenic T-cell responses by cilostazol is associated with upregulation of regulatory T cells. Neuroreport (2010) 0.83
Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension. Eur J Pharmacol (2007) 0.83
PAI-1 plays an important role in liver failure after excessive hepatectomy in the rat. J Surg Res (2007) 0.82
Hepatic stellate cells and alcoholic liver disease. Rev Esp Enferm Dig (2006) 0.82
Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function. Br J Surg (2001) 0.82
Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature. Liver Transpl (2012) 0.81
Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3). FASEB J (2013) 0.81
Thrombocytopenia after liver transplantation. Transplant Proc (1988) 0.81
Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation. Transplant Proc (2014) 0.81
Hepatic microcirculatory disturbances due to portal vein clamping in the orthotopic rat liver transplantation model. Transplantation (1991) 0.81
Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review. Clin Transplant (2012) 0.80
Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver. Prostaglandins Other Lipid Mediat (2004) 0.79
ADP-dependent platelet function prior to and in the early course of pediatric liver transplantation and persisting thrombocytopenia are positively correlated with ischemia/reperfusion injury. Transpl Int (2010) 0.78
Application of an artificial pancreas for a liver transplant recipient. Exp Clin Transplant (2014) 0.77
Endothelin-1 is involved in hepatic sinusoidal vasoconstriction after ischemia and reperfusion. Transpl Int (1994) 0.77
Extravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case report. Exp Ther Med (2015) 0.76